转变他类药物用于甲状腺功能障碍预防的遗传洞察:一种药物向的门德尔式随机化研究
Anqi Huang1,2, Xinyi Wu1,2, Jiaqi Lin1,2
1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Frontiers in endocrinology
|March 1, 2024
概括
类他类药物 (HMGCR抑制剂) 可能会降低甲状腺功能升高的风险,这表明除了降低脂质之外还有新的治疗途径. 胰岛素类生长因子1 (IGF-1) 可能会调解这种效果,因此需要进一步研究.
科学领域:
- 内分泌学和代谢性疾病.
- 药物基因组学 药物基因组学
- 遗传流行病学遗传流行病学
背景情况:
- 目前治疗甲状腺功能障碍的方法有局限性和副作用.
- 用于降低脂质的他类药物已经显示出降低甲状腺眼睛疾病风险的潜力.
研究的目的:
- 调查基因代理降脂药物和甲状腺功能障碍之间的因果关系.
- 探索潜在的生物标志物,调解降脂药物标与甲状腺功能障碍之间的关联.
主要方法:
- 一项针对药物的门德尔随机化 (MR) 研究,使用来自全基因组关联研究 (GWAS) 的遗传变异.
- 利用低密度脂蛋白 (LDL) 或甘油三 (TG) 标和甲状腺功能障碍结果的遗传数据.
- 采用逆变量加权MR (IVW-MR) 和局部化分析,随后采用两步MR进行中介分析.
主要成果:
- 基因模仿3 - 基-3 - 甲基氨基酶还原酶 (HMGCR) 抑制剂 (他类药物) 与甲状腺功能增强症风险降低有显著关联.
- 胰岛素样生长因子1 (IGF-1) 被确定为潜在的调解者,解释了2.108%的HMGCR抑制-甲状腺功能障碍相关性.
结论:
- 抑制HMGCR代表了甲状腺功能障碍症的有前途的治疗策略,其机制可能超出脂质代谢范围.
- 需要进一步的实验室和临床研究来验证这些发现并阐明潜在的机制.
关键词:
3-基-3-甲基谷氨基酶减少酶.门德尔的随机化血液中的脂质 血脂药物目标是药物目标.遗传学 遗传学 遗传学 是一个甲状腺功能过强症 甲状腺功能过强症斯塔丁是一个国家.甲状腺是什么?甲状腺是什么?更多相关视频
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.7K
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
13.4K
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
